Answers are grounded in this paper and cite their sources.
All articles of this category An improved synthetic procedure for 5,8-dibromo-7,10-dihydroxy-2-methyl-6 H -pyrazolo[4,5,1- de ]acridin-6-one (4) , an intermediate of a novel class of antitumor agents, was developed. An effective introduction of a hydroxy group to the C10 of 5,8-dibromo-7-hydroxy-2-methyl-6 H -pyrazolo[4,5,1- de ]acridin-6-one (2b) was accomplished in two steps via the oxidation of 2b to the corresponding quinone using hypervalent iodine reagent in an acidic medium, followed by reduction of the resulting quinone upon treatment with aqueous sodium hydrosulfite. pyrazoloacridine derivative - hypervalent iodine oxidation - quinone intermediate of antitumor agent - fused heterocyclic compound
No takes yet. Share an insight, caveat, or question.
Kato et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: